GIPM
CLBT icon

G2 Investment Partners Management’s Cellebrite CLBT Stock Holding History

G2 Investment Partners Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,000
Closed -$413K – 79
2026
Q1 		$413K Sell
30,000
-292,071
-91% -$4.4M 0.1% 70
2025
Q4 		$5.81M Buy
322,071
+222,071
+222% +$3.99M 1.38% 30
2025
Q3 		$1.85M Buy
+100,000
New +$1.57M 0.37% 56
2025
Q2 		– Sell
-37,671
Closed -$732K – 62
2025
Q1 		$732K Sell
37,671
-272,048
-88% -$5.73M 0.24% 50
2024
Q4 		$6.82M Sell
309,719
-170,114
-35% -$3.27M 1.76% 25
2024
Q3 		$8.08M Buy
479,833
+279,833
+140% +$4.15M 2.3% 19
2024
Q2 		$2.39M Buy
+200,000
New +$2.23M 0.62% 51
2023
Q4 		– Sell
-308,000
Closed -$2.36M – 90
2023
Q3 		$2.36M Buy
+308,000
New +$2.31M 0.57% 47

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

G2 Investment Partners Management's CLBT Position: Q2 2026 in Review

G2 Investment Partners Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 30,000 shares — an estimated $413K sold.

G2 Investment Partners Management first reported a position in CLBT in Q3 2023 and held it in 8 quarters. The position peaked at $8.08M in Q3 2024. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • G2 Investment Partners Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • G2 Investment Partners Management sold 30,000 Cellebrite shares in Q2 2026, an estimated $413K.
  • G2 Investment Partners Management first reported a position in Cellebrite in Q3 2023 and held it in 8 quarters.
  • G2 Investment Partners Management's Cellebrite position peaked at $8.08M in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on G2 Investment Partners Management's 13F filing for Q2 2026, filed 14 Aug 2026.